4.5 Article

Host nuclear factor-κB activation potentiates lung cancer metastasis

Journal

MOLECULAR CANCER RESEARCH
Volume 6, Issue 3, Pages 364-371

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1541-7786.MCR-07-0309

Keywords

-

Funding

  1. NHLBI NIH HHS [HL61419, HL66196] Funding Source: Medline

Ask authors/readers for more resources

Epidemiologic and experimental evidence suggests that a link exists between inflammation and cancer, although this relationship has only recently begun to be elucidated for lung cancer, the most frequently fatal human tumor. Nuclear factor-kappa B (NF-kappa B), a transcription factor that controls innate immune responses in the lungs, has been implicated as an important determinant of cancer cell proliferative and metastatic potential; however, its role in lung tumorigenesis is uncertain. Here, we specifically examine the role of NF-kappa B-induced airway inflammation in lung cancer metastasis using a model of intravenous injection of Lewis lung carcinoma cells into immunocompetent C57BI/6 mice. Induction of lung inflammation by direct and specific NF-kappa B activation in airway epithelial cells potentiates lung adenocarcinoma metastasis. Moreover, we identify resident lung macrophages as crucial effectors of lung susceptibility to metastatic cancer growth. We conclude that NF-kappa B activity in host tissue is a significant factor in the development of lung metastasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available